Company
Immunophotonics
Pioneering Interventional Immuno-Oncology
Also known as IMMUNOPHOTONICS, INC.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- St. Louis, Missouri, United States
- Legal name
- IMMUNOPHOTONICS, INC.
- immunophotonics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Immunophotonics is a privately owned clinical-stage biotech company that is pioneering the burgeoning field of Interventional Immuno-Oncology through the development of novel treatments for solid-tumor cancers.
Funding snapshot
- Total raised
- $8.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series C2026-09-01
Funding rounds
- Series C
- 2026-09-01
- Round, 2025
- $10.1M2025-07-14, SEC form D sold, 45 investors
- Round, 2024
- $1.5M2024-02-29, SEC form D sold, 17 investors
- Round, 2023
- $3.5M2023-01-06, SEC form D sold, 22 investors
- Round, 2014
- $2.5M2014-06-12, SEC form D sold, 28 investors
- Round, 2011
- $100K2011-06-14, SEC form D sold, 1 investor
- Round, 2010
- $550K2010-04-27, SEC form D sold, 2 investors
Products
- Other
- IP-001
- Web
- IP-001
Loading relationship preview